Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
681.5 DKK | -2.36% | -1.30% | +82.61% |
Mar. 20 | Zealand Pharma A/S Approves Appointments to the Board | CI |
Mar. 14 | Global markets live: Robinhood, Dollar General, KKR, Boeing, Oracle... |
Sales 2024 * | 806M 117M | Sales 2025 * | 1.29B 187M | Capitalization | 42.44B 6.15B |
---|---|---|---|---|---|
Net income 2024 * | -358M -51.86M | Net income 2025 * | -256M -37.08M | EV / Sales 2024 * | 49.3 x |
Net cash position 2024 * | 2.69B 389M | Net cash position 2025 * | 2.77B 401M | EV / Sales 2025 * | 30.8 x |
P/E ratio 2024 * |
-119
x | P/E ratio 2025 * |
-1,230
x | Employees | 253 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.24% |
Latest transcript on Zealand Pharma A/S
1 day | -2.36% | ||
1 week | -1.30% | ||
Current month | +2.64% | ||
1 month | +9.92% | ||
3 months | +82.71% | ||
6 months | +128.84% | ||
Current year | +82.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 09-12-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Ivan M. Møller
COO | Chief Operating Officer | 52 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Kruimer
BRD | Director/Board Member | 66 | 19-04-03 |
Chairman | 69 | 14-12-31 | |
Kirsten Drejer
BRD | Director/Board Member | 68 | 18-04-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 681.5 | -2.36% | 290,377 |
24-03-26 | 698 | -0.57% | 225,463 |
24-03-25 | 702 | -2.36% | 179,157 |
24-03-22 | 719 | +1.05% | 232,033 |
24-03-21 | 711.5 | +3.04% | 575,472 |
Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.61% | 6.16B | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.51% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |